Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|September 11, 2003
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatmentG Hudelist, W J Köstler, J Attems, et al.
Breast Cancer Research and Treatment|January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I studyUrsula Wiedermann, C Wiltschke, J Jasinska, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
The Journal of Endocrinology|April 1, 1989
Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up studyC Müller, C C Zielinski, W Kalinowski, et al.
Annals of the Rheumatic Diseases|June 1, 1987
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigensJ S Smolen, J H Klippel, E Penner, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 19, 2018
European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic TherapyN Touati, P Schöffski, S Litière, et al.
Breast Cancer Research and Treatment|January 1, 1996
Impaired hemorheology in patients with postmastectomy lymphedemaM P Djavanmard, I Michl, M Korpan, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factorH Stöger, H Samonigg, M Krainer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2012
Adjuvant therapy in primary GIST: state-of-the-artP Reichardt, J-Y Blay, I Boukovinas, et al.
Pageof 16